- Home
- LGCL vs INMB Comparison
LGCL vs INMB Comparison
Compare LGCL & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- INMB
- Stock Information
- Founded
- LGCL 2009
- INMB 2015
- Country
- LGCL China
- INMB United States
- Employees
- LGCL N/A
- INMB N/A
- Industry
- LGCL
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- LGCL
- INMB Health Care
- Exchange
- LGCL NYSE
- INMB Nasdaq
- Market Cap
- LGCL 119.4M
- INMB 68.9M
- IPO Year
- LGCL 2024
- INMB 2019
- Fundamental
- Price
- LGCL $1.07
- INMB $2.31
- Analyst Decision
- LGCL
- INMB Buy
- Analyst Count
- LGCL 0
- INMB 4
- Target Price
- LGCL N/A
- INMB $9.53
- AVG Volume (30 Days)
- LGCL 850.2K
- INMB 6.9M
- Earning Date
- LGCL 01-01-0001
- INMB 07-31-2025
- Dividend Yield
- LGCL N/A
- INMB N/A
- EPS Growth
- LGCL N/A
- INMB N/A
- EPS
- LGCL 0.07
- INMB N/A
- Revenue
- LGCL $145,690,427.00
- INMB $50,000.00
- Revenue This Year
- LGCL N/A
- INMB $82.14
- Revenue Next Year
- LGCL N/A
- INMB $28,750.98
- P/E Ratio
- LGCL $15.47
- INMB N/A
- Revenue Growth
- LGCL N/A
- INMB N/A
- 52 Week Low
- LGCL $0.28
- INMB $1.89
- 52 Week High
- LGCL $3.31
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- INMB 26.84
- Support Level
- LGCL N/A
- INMB $2.22
- Resistance Level
- LGCL N/A
- INMB $2.49
- Average True Range (ATR)
- LGCL 0.00
- INMB 0.94
- MACD
- LGCL 0.00
- INMB -0.24
- Stochastic Oscillator
- LGCL 0.00
- INMB 4.31
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.